Total medical devices industry cross border deals worth $2.3bn were announced globally for February 2022, with the $556.1m private equity deal for 60.8% stake with Classys being the sector’s biggest investment, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 21.5% over the previous month of $2.89bn and a drop of 67.1% when compared with the last 12-month average of $6.9bn.

In terms of number of cross border deals, the sector saw a rise of 13.79% with 66 deals in February 2022 when compared to the last 12-month average of 58 deals.

In value terms, North America led the activity with cross border deals worth $1.06bn in February 2022.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

medical devices industry cross border deals in February 2022: Top deals

The top five cross border deals accounted for 63.05% of the overall value during February 2022.

The combined value of the top five cross border deals stood at $1.43bn, against the overall value of $2.3bn recorded for the month.

The top five medical devices industry cross border deals of February 2022 tracked by GlobalData were:

1) Bain Capital Private Equity $556.1m private equity deal for 60.8% stake in Classys

2) The $325m venture financing of Somatus by Anthem,Blue Venture Fund,Deerfield ManagementLP,Fidelity Management & Research,Flare Capital Partners,General Insuranceof India,Inova Health System,Longitude Capital Management Co,Optum Ventures,RA Capital Management and Wellington ManagementLLP

3) Dreamtech $227.57m acquisition deal for 9.07% stake with Cardiac Insight

4) The $210m private equity deal with Micro Life Sciences by South Elm Investments B V

5) Alumni Ventures Group,aMoon Funds,Cowen Healthcare Investments,Echo Health Ventures,Hitachi Ventures,Khosla Ventures,Laurion Capital Management,Monashee Investment Management,Neuberger Berman Group,Northpond Ventures and Optum Ventures $110m venture financing deal with Scipher Medicine